Chromadex Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1710774076
USD
4.66
-0.11 (-2.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Chromadex Corp.
Nature's Sunshine Products, Inc.
USANA Health Sciences, Inc.
ProPhase Labs, Inc.
Upexi, Inc.
Natural Alternatives International, Inc.
LifeVantage Corp.
Revolution Medicines, Inc.
Cidara Therapeutics, Inc.
MIRA Pharmaceuticals, Inc.
Bright Green Corp.

Why is Chromadex Corp. ?

1
With a growth in Operating Profit of 5.87%, the company declared Outstanding results in Sep 25
  • The company has declared positive results for the last 6 consecutive quarters
  • NET PROFIT(HY) At USD 8.19 MM has Grown at 106.59%
  • OPERATING CASH FLOW(Y) Highest at USD 21.35 MM
  • ROCE(HY) Highest at 38.9%
2
With ROE of 28.91%, it has a fair valuation with a 5.44 Price to Book Value
  • Over the past year, while the stock has generated a return of -40.79%, its profits have risen by 335.6% ; the PEG ratio of the company is 0.1
3
High Institutional Holdings at 47.32%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 5.85% over the previous quarter.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Chromadex Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Chromadex Corp. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Chromadex Corp.
-40.79%
0.91
56.39%
S&P 500
14.9%
0.77
19.29%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
16.99%
EBIT Growth (5y)
24.73%
EBIT to Interest (avg)
-3.81
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.99
Sales to Capital Employed (avg)
2.44
Tax Ratio
3.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
47.32%
ROCE (avg)
306.58%
ROE (avg)
5.86%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
5.44
EV to EBIT
16.63
EV to EBITDA
15.86
EV to Capital Employed
43.60
EV to Sales
2.57
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
262.14%
ROE (Latest)
28.91%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
NET PROFIT(HY)

At USD 8.19 MM has Grown at 106.59%

OPERATING CASH FLOW(Y)

Highest at USD 21.35 MM

ROCE(HY)

Highest at 38.9%

NET SALES(Q)

Highest at USD 33.99 MM

RAW MATERIAL COST(Y)

Fallen by -1.65% (YoY

CASH AND EQV(HY)

Highest at USD 124.76 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 15.99 times

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Chromadex Corp.

Net Profit
At USD 8.19 MM has Grown at 106.59%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
Highest at USD 33.99 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD 21.35 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
At USD 33.99 MM has Grown at 16.89%
over average net sales of the previous four periods of USD 29.08 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Cash and Eqv
Highest at USD 124.76 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio
Highest at 15.99 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -1.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales